TABLE 4.
Sample identification of selected candidate biomarkers
| m/z value (/1,000) | Protein identity | Positions | No. of ions sequenced (% sequence coveragea) | Predicted mass (Da) | Predicted pI |
|---|---|---|---|---|---|
| 8.1 | C-terminal truncation of C3a anaphylatoxin desArg (Ctt-C3a) | 1-68 | 4 (50) | 8,126.52 | 9.38 |
| 9.3 | N-terminal truncation of apolipoprotein A1 (Ntt-ApoA1a) | 161-243 | 8 (84) | 9,306.59 | 6.77 |
| 10.1 | N-terminal truncation of apolipoprotein A1 (Ntt-ApoA1b) | 154-243 | 8 (78) | 10,069.46 | 7.15 |
| 13.6 | N-terminal truncation of apolipoprotein A1 (Ntt-ApoA1c) | 124-243 | 6 (54) | 13,570.40 | 6.6 |
| 24.7 | C-terminal truncation of apolipoprotein A1 (Ctt-ApoA1) | 1-214 | 7 (36) | 24,756.76 | 5.15 |
| 28.9 | C-terminal truncation of fibronectin (Ctt-Fbn) | 1-258 | 7 (43) | 28,730.95 | 7.49 |
a
Percentage of predicted tryptic peptides sequenced by tandem mass spectrometry.